Double Allogenic Mesenchymal Stem Cells Transplantations Could Not Enhance Therapeutic Effect Compared with Single Transplantation in Systemic Lupus Erythematosus

The clinical trial of allogenic mesenchymal stem cells (MSCs) transplantation for refractory SLE patients has shown significant safety and efficacy profiles. However, the optimum frequency of the MSCs transplantation (MSCT) is unknown. This study was undertaken to observe whether double transplantat...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Dandan Wang, Kentaro Akiyama, Huayong Zhang, Takayoshi Yamaza, Xia Li, Xuebing Feng, Hong Wang, Bingzhu Hua, Bujun Liu, Huji Xu, Wanjun Chen, Songtao Shi, Lingyun Sun
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2012-01-01
coleção:	Clinical and Developmental Immunology
Acesso em linha:	http://dx.doi.org/10.1155/2012/273291
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!